We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Antisense Gene Therapy Corrects Spinal Muscular Atrophy

By LabMedica International staff writers
Posted on 13 Aug 2009
Print article
Hereditary spinal muscular atrophy (SMA), the second-leading genetic cause of infant mortality in the world, has been successfully treated using antisense gene therapy. SMA affects from 1 in 6,000 to 1 in 10,000 children born each year, and 1 in 40 are carriers of the disease.

Investigators from Iowa State University (Ames, USA) worked with cultures of cells obtained from SMA victims. These cells carried both the mutated form of the SMN1 (survival motor neuron 1) gene and the ineffective form of the SMN2 gene. Neither of these two genes was capable of synthesizing SMN protein, lack of which causes SMA.

In a study published in the July 1, 2009, online edition of the journal RNA Biology, the investigators described a method for correcting SMA by treating the cells with a small antisense oligonucleotide directed at the SMN2 gene. The nucleotide bound and blocked a "junk DNA” codon on the SMN2 gene, a situation that enabled RNA binding and subsequent synthesis of SMN protein. The amount of SMN protein that was made was enough to reverse the effects of the disease.

"The significance of our work is that we have this stuff called junk DNA in SMN2,” said senior author Dr. Ravindra Singh, associate professor of biomedical sciences at Iowa State University. "We found that we could get SMN2 to behave as SMN1 by introducing a small oligonucleotide. It is a very simple experiment if you think about it. Our cells are healthy and survive. From that point of view, this is a major achievement. If this is a model disease, meaning we succeed in treating SMA, we will know how to correct splicing of other genes in other diseases. We know that Parkinson's disease, Alzheimer's disease, cystic fibrosis, multiple sclerosis, and cancer all come from genes that are aberrantly spliced.”

Related Links:
Iowa State University


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Chlamydia Test Kit
CHLAMYTOP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.